Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Decreased insulin degradation Q6
Even where human research exists, mechanistic interpretation remains incomplete
The current FDA status of BPC-157 is that of an unapproved drug compound with no active Investigational New Drug (IND) application accepted for human clinical trials as of available records
(Aetna, FSBP)
Research material data sheetCAS Number: 89030-95-5Molecular Formula: C14H24CuN6O4Molecular Weight: 403.93 g/molPurity: 99%Physical Form: lyophilized powderStorage: lyophilized form at -20 C, up to 24 months
Behaviour is affected in ADHD and is due to imbalances of specific neurotransmitters (i.e
US$ 23.18
US$ 28.86
US$ 25.20
US$ 23.89
US$ 20.07
